Observational analysis reveals choreiform movement disorder responsive to tetrabenazine in a girl with 22q11.2DS, suggesting potential treatment pathways.
22q11.2 deletion syndrome (22q11.2DS) is the most common chromosomal microdeletion disorder, presenting with a broad spectrum of congenital abnormalities and neuropsychiatric symptoms. Movement disorder is one of the most common neurological manifestation of the syndrome. The literature reports that early Parkinson's disease and dystonia in particular are associated with the syndrome. We here describe the first known case of choreiform movement disorder in a girl suffering from 22q11.2DS, responsive to tetrabenazine after a relapsing-remitting course.
No takes yet. Share an insight, caveat, or question.
Brunetti et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: